Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Taiwan raises COVID alert islandwide, but gets vaccine boost

Published 05/18/2021, 11:57 PM
Updated 05/19/2021, 04:21 AM
© Reuters. A medical worker guides people on how to get a rapid test following a surge of coronavirus disease (COVID-19) infections in Taipei, Taiwan, May 19, 2021. REUTERS/Ann Wang

© Reuters. A medical worker guides people on how to get a rapid test following a surge of coronavirus disease (COVID-19) infections in Taipei, Taiwan, May 19, 2021. REUTERS/Ann Wang

(Adds dropped letter in headline)

TAIPEI (Reuters) - Taiwan raised its COVID-19 alert level for the whole island on Wednesday as domestic cases continued to rise, but will get 400,000 more AstraZeneca (NASDAQ:AZN) Plc COVID-19 vaccine doses from the COVAX global sharing programme.

Taiwan has reported more than 1,000 new infections during the past week or so, leading to new curbs in the capital, Taipei, and shocking a population that had become accustomed to life carrying on almost normally.

Announcing another 267 local infections, up from 240 on Tuesday, Health Minister Chen Shih-chung said that although the across Taiwan.

There was no need to order a full lockdown for now, and people should not worry too much, he added.

"At present medical capacity is sufficient, so please don't worry," Chen added.

The new curbs for Taiwan restrict personal gatherings and close entertainment venues, steps already in effect in Taipei since the weekend.

In a boost for Taiwan's fight against the pandemic, Chen said more than 410,000 vaccine doses from COVAX would arrive Wednesday afternoon, which he described as "very valuable" and would be prioritised for front-line health care workers.

It has only received a little more than 300,000 doses to date, all from AstraZeneca. More than two-thirds of those have been distributed.

Taiwan has said it expected to get more than 1 million AstraZeneca shots via COVAX in total.

Taiwan has ordered 20 million doses, mostly from AstraZeneca but also from Moderna (NASDAQ:MRNA) Inc, though global shortages have curtailed supplies.

In a statement on Wednesday, Taiwan's Centres for Disease Control said after a virtual workshop on vaccines on Tuesday with the top U.S., British, Japanese and Australian diplomats in Taipei that vaccines must be fairly distributed.

"Fair access to effective vaccines is the ultimate means to curb the global COVID-19 pandemic. We look forward to more effective and sufficient vaccine development and marketing, and call on all countries to work together to end the COVID-19 pandemic," it said.

Taiwan is mobilising its diplomats to try to speed up access to more vaccines, and is in talks with the United States for a share of the COVID-19 shots President Joe Biden plans to send abroad.

Brent Christensen, the de facto U.S. ambassador to Taiwan, said at the same event that "talking about COVID-19 vaccines can be a sensitive subject", according to a copy of his remarks published by his office.

© Reuters. Soldiers in protective suits disinfect a metro station following a surge of coronavirus disease (COVID-19) infections in Taipei, Taiwan May 19, 2021. REUTERS/Ann Wang

"We recognise that each country and region is at different stages in their COVID-19 vaccination programmes," the remarks said. "Unfortunately, many still face difficulties gaining access to vaccines."

Taiwan has reported 2,533 cases since the pandemic began, including 14 deaths.

Latest comments

they can't determine what is good for them. they only know how to lick their enemies.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.